<DOC>
	<DOCNO>NCT00171405</DOCNO>
	<brief_summary>The purpose study collect long-term ( 12 month ) safety data aliskiren 300 mg take combination HCTZ 25 mg .</brief_summary>
	<brief_title>A Clinical Study Evaluate Long-term Safety ( 12 Months ) Combination Aliskiren 300 mg Hydrochlorothiazide 25 mg</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>1. successful completion CSPP100A2302 core study least eight month combination treatment aliskiren 300 mg HCTZ 25 mg , i.e. , patient receive aliskiren 300 mg HCTZ 25 mg Month 4 core study complete core study . 2. absence ongoing severe adverse event Visit 10 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>hypertension</keyword>
	<keyword>aliskiren</keyword>
	<keyword>hydrochlorothiazide</keyword>
</DOC>